Trinity find may help defeat cancer drug resistance

Irish researchers have discovered a molecule that could improve targeted treatments for breast cancer and a number of other cancers.

Scientists at Trinity College Dublin believe the new biomarker could be the key to overcoming resistance to drugs such as Herceptin, which targets HER2 positive cancers.

HER2 positive breast cancer tends to be more aggressive than other types of breast cancer and is also less responsive to hormone treatments.